BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38393715)

  • 1. Machine Learning-Derived Baseline Visual Field Patterns Predict Future Glaucoma Onset in the Ocular Hypertension Treatment Study.
    Singh RK; Smith S; Fingert J; Gordon M; Kass M; Scheetz T; Segrè AV; Wiggs J; Elze T; Zebardast N
    Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):35. PubMed ID: 38393715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Correlates of Computationally Derived Visual Field Defect Archetypes in Patients from a Glaucoma Clinic.
    Cai S; Elze T; Bex PJ; Wiggs JL; Pasquale LR; Shen LQ
    Curr Eye Res; 2017 Apr; 42(4):568-574. PubMed ID: 27494512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.
    ; ; Gordon MO; Torri V; Miglior S; Beiser JA; Floriani I; Miller JP; Gao F; Adamsons I; Poli D; D'Agostino RB; Kass MA
    Ophthalmology; 2007 Jan; 114(1):10-9. PubMed ID: 17095090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study.
    Levine RA; Demirel S; Fan J; Keltner JL; Johnson CA; Kass MA;
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3896-903. PubMed ID: 16936102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rate of visual field change in the ocular hypertension treatment study.
    Demirel S; De Moraes CG; Gardiner SK; Liebmann JM; Cioffi GA; Ritch R; Gordon MO; Kass MA;
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):224-7. PubMed ID: 22159015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting Glaucoma in the Ocular Hypertension Study Using Deep Learning.
    Fan R; Bowd C; Christopher M; Brye N; Proudfoot JA; Rezapour J; Belghith A; Goldbaum MH; Chuter B; Girkin CA; Fazio MA; Liebmann JM; Weinreb RN; Gordon MO; Kass MA; Kriegman D; Zangwill LM
    JAMA Ophthalmol; 2022 Apr; 140(4):383-391. PubMed ID: 35297959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine-Identified Patterns of Visual Field Loss and an Association with Rapid Progression in the Ocular Hypertension Treatment Study.
    Yousefi S; Pasquale LR; Boland MV; Johnson CA
    Ophthalmology; 2022 Dec; 129(12):1402-1411. PubMed ID: 35817199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma.
    Medeiros FA; Weinreb RN; Zangwill LM; Alencar LM; Sample PA; Vasile C; Bowd C
    Ophthalmology; 2008 Jun; 115(6):934-40. PubMed ID: 17936908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cohort Study of Race/Ethnicity and Incident Primary Open-Angle Glaucoma Characterized by Autonomously Determined Visual Field Loss Patterns.
    Kang JH; Wang M; Frueh L; Rosner B; Wiggs JL; Elze T; Pasquale LR
    Transl Vis Sci Technol; 2022 Jul; 11(7):21. PubMed ID: 35877093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The accuracy and clinical application of predictive models for primary open-angle glaucoma in ocular hypertensive individuals.
    Ocular Hypertension Treatment Study Group and the European Glaucoma Prevention Study Group
    Ophthalmology; 2008 Nov; 115(11):2030-6. PubMed ID: 18801578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.
    Gordon MO; Beiser JA; Brandt JD; Heuer DK; Higginbotham EJ; Johnson CA; Keltner JL; Miller JP; Parrish RK; Wilson MR; Kass MA
    Arch Ophthalmol; 2002 Jun; 120(6):714-20; discussion 829-30. PubMed ID: 12049575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.
    Salvetat ML; Zeppieri M; Tosoni C; Brusini P;
    Eye (Lond); 2016 Jun; 30(6):784-95. PubMed ID: 27174381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mean rate of progression of visual fields in patients with primary open-angle glaucoma and ocular hypertension attending a tertiary care center in South India - A prospective cohort study using FORUM
    Smithin SS; Manju M; Chandran P; Dhavalikar M; Menaka SV; Balagiri K; Venkataraman G
    Indian J Ophthalmol; 2023 Jul; 71(7):2733-2738. PubMed ID: 37417113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.
    Keltner JL; Johnson CA; Anderson DR; Levine RA; Fan J; Cello KE; Quigley HA; Budenz DL; Parrish RK; Kass MA; Gordon MO;
    Ophthalmology; 2006 Sep; 113(9):1603-12. PubMed ID: 16949445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unsupervised Machine Learning Shows Change in Visual Field Loss in the Idiopathic Intracranial Hypertension Treatment Trial.
    Doshi H; Solli E; Elze T; Pasquale LR; Wall M; Kupersmith MJ
    Ophthalmology; 2022 Aug; 129(8):903-911. PubMed ID: 35378137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study.
    Weinreb RN; Zangwill LM; Jain S; Becerra LM; Dirkes K; Piltz-Seymour JR; Cioffi GA; Trick GL; Coleman AL; Brandt JD; Liebmann JM; Gordon MO; Kass MA;
    Ophthalmology; 2010 Sep; 117(9):1674-83. PubMed ID: 20633931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Impact of Uveitis on Visual Field Progression Using Large-Scale Real-World Data.
    Liu X; Kelly SR; Montesano G; Bryan SR; Barry RJ; Keane PA; Denniston AK; Crabb DP
    Am J Ophthalmol; 2019 Nov; 207():144-150. PubMed ID: 31251907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsupervised machine learning with independent component analysis to identify areas of progression in glaucomatous visual fields.
    Sample PA; Boden C; Zhang Z; Pascual J; Lee TW; Zangwill LM; Weinreb RN; Crowston JG; Hoffmann EM; Medeiros FA; Sejnowski T; Goldbaum M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3684-92. PubMed ID: 16186350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.
    Zangwill LM; Jain S; Dirkes K; He F; Medeiros FA; Trick GL; Brandt JD; Cioffi GA; Coleman AL; Liebmann JM; Piltz-Seymour JR; Gordon MO; Kass MA; Weinreb RN;
    Am J Ophthalmol; 2013 Jun; 155(6):971-82. PubMed ID: 23497845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography.
    Zhang X; Loewen N; Tan O; Greenfield DS; Schuman JS; Varma R; Huang D;
    Am J Ophthalmol; 2016 Mar; 163():29-37. PubMed ID: 26627918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.